Chulani Karunatilake
Technik-/Wissenschafts-/F&E-Leiter bei WEREWOLF THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Chulani Karunatilake is currently the Chief Technology Officer at Werewolf Therapeutics, Inc. He previously worked as Vice President at Nektar Therapeutics and Senior Vice President-Technical Operations at Maverick Therapeutics, Inc. He holds a doctorate degree from the University of Illinois and an undergraduate degree from the University of Colombo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Chulani Karunatilake
| Unternehmen | Position | Beginn |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.06.2021 |
Ehemalige bekannte Positionen von Chulani Karunatilake
| Unternehmen | Position | Ende |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Corporate Officer/Principal | - |
Ausbildung von Chulani Karunatilake
| University of Illinois | Doctorate Degree |
| University of Colombo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
